Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.16 +0.00 (+0.00%)
As of: Sep 10, 2026 · 3:07 PM EDT

Drugs Made In America Acquisition II Corp. (DMII) EPS (Basic) (2025 - 2026)

Drugs Made In America Acquisition's (DMII) quarterly EPS (Basic) came in at $0.05 in Q2 2026, down 37.56% quarter-over-quarter from $0.09 in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Drugs Made In America Acquisition II Corp. (DMII) EPS (Basic) (2025 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported EPS (Basic) for 2 consecutive years, with $0.05 the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Dec 31, 2025 0.09
Sep 30, 2025 0.00